Samsung has announced a collaborative research initiative with the Massachusetts General Hospital (MGH) Diabetes Research Centre to investigate how wearable technology can assist patients on GLP-1 medications in managing muscle loss. The clinical study will leverage the Galaxy Watch 8, which launched last year, alongside the Samsung Health ecosystem. Researchers plan to evaluate the feasibility…
Novo Nordisk shares received a much-needed end of the year boost as the Wegovy maker became the first drugmaker to secure approval of a GLP-1 pill for weight loss, in what one analyst called a “redemption for the investors” after the stock’s worst year ever. The U.S. Food and Drug Administration’s approval of Novo Nordisk’s…
Nairobi — Health advocates are calling on African governments to leverage new World Health Organisation (WHO) guidelines on the use of Glucagon-Like Peptide-1 (GLP-1) therapies to prevent and treat obesity, warning that failure to act could deepen the continent’s growing non-communicable disease burden. In a statement, senior researcher and Stowelink Foundation founder Stephen Ogweno said…
